Medicine and Dentistry
Eptifibatide
100%
ST Elevation
83%
Acute Coronary Syndrome
83%
Patient
66%
Combination Therapy
50%
Platelet Glycoprotein
33%
Glycoprotein IIb/IIIa Inhibitors
33%
Placebo
33%
Receptor
16%
Myocardial Infarction
16%
Patient Care
16%
Antithrombotic
16%
Physical Disease by Body Function
16%
Unstable Angina Pectoris
16%
Fibrinogen Receptor
16%
Percutaneous Coronary Intervention
16%
Drug Infusion
16%
Introspection
16%
Inpatient
16%
Incidence
16%
Physician
16%
INIS
patients
100%
coronaries
100%
elevation
83%
management
66%
glycoproteins
50%
therapy
33%
pharmaceuticals
16%
drugs
16%
risks
16%
interventions
16%
suppression
16%
safety
16%
receptors
16%
death
16%
california
16%
reduction
16%
infusion
16%
symptoms
16%
new jersey
16%
myocardial infarction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Eptifibatide
100%
Acute Coronary Syndrome
83%
Clinical Study
50%
Receptor
16%
Heart Infarction
16%
Anticoagulant Agent
16%
Physical Disease by Body Function
16%
Unstable Angina Pectoris
16%
Fibrinogen Receptor
16%
Death
16%
Incidence
16%
Biochemistry, Genetics and Molecular Biology
ST Elevation
83%
Eptifibatide
83%
Glycoprotein IIb/IIIa
50%
Introspection
16%
Reduction (Chemistry)
16%
Incidence
16%